Lane HC - Search Results

1

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.

Mulangu S, Dodd LE, Davey RT Jr, Tshiani Mbaya O, Proschan M, Mukadi D, Lusakibanza Manzo M, Nzolo D, Tshomba Oloma A, Ibanda A, Ali R, Coulibaly S, Levine AC, Grais R, Diaz J, Lane HC, Muyembe-Tamfum JJ; PALM Writing Group; Sivahera B, Camara M, Kojan R, Walker R, Dighero-Kemp B, Cao H, Mukumbayi P, Mbala-Kingebeni P, Ahuka S, Albert S, Bonnett T, Crozier I, Duvenhage M, Proffitt C, Teitelbaum M, Moench T, Aboulhab J, Barrett K, Cahill K, Cone K, Eckes R, Hensley L, Herpin B, Higgs E, Ledgerwood J, Pierson J, Smolskis M, Sow Y, Tierney J, Sivapalasingam S, Holman W, Gettinger N, Vallée D, Nordwall J; PALM Consortium Study Team. Mulangu S, et al. Among authors: lane hc. N Engl J Med. 2019 Dec 12;381(24):2293-2303. doi: 10.1056/NEJMoa1910993. Epub 2019 Nov 27. N Engl J Med. 2019. PMID: 31774950 Free PMC article. Clinical Trial.

2

Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.

Kovacs JA, Baseler M, Dewar RJ, Vogel S, Davey RT Jr, Falloon J, Polis MA, Walker RE, Stevens R, Salzman NP, Lane HC. Kovacs JA, et al. Among authors: lane hc. N Engl J Med. 1995 Mar 2;332(9):567-75. doi: 10.1056/NEJM199503023320904. N Engl J Med. 1995. PMID: 7646637 Free article. Clinical Trial.

3

A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus.

Tavel JA, Sereti I, Walker RE, Hahn B, Kovacs JA, Jagannatha S, Davey RT Jr, Falloon J, Polis MA, Masur H, Metcalf JA, Stevens R, Rupert A, Baseler M, Lane HC. Tavel JA, et al. Among authors: lane hc. J Infect Dis. 2003 Aug 15;188(4):531-6. doi: 10.1086/377285. Epub 2003 Jul 31. J Infect Dis. 2003. PMID: 12898439 Clinical Trial.

4

Increases in CD4+ T lymphocytes occur without increases in thymic size in HIV-infected subjects receiving interleukin-2 therapy.

Lu AC, Jones EC, Chow C, Miller KD, Herpin B, Rock-Kress D, Metcalf JA, Lane HC, Kovacs JA. Lu AC, et al. Among authors: lane hc. J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):299-303. doi: 10.1097/00126334-200311010-00007. J Acquir Immune Defic Syndr. 2003. PMID: 14600575 Clinical Trial.

5

Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection.

Farel CE, Chaitt DG, Hahn BK, Tavel JA, Kovacs JA, Polis MA, Masur H, Follmann DA, Lane HC, Davey RT Jr. Farel CE, et al. Among authors: lane hc. Blood. 2004 May 1;103(9):3282-6. doi: 10.1182/blood-2003-09-3283. Epub 2004 Jan 15. Blood. 2004. PMID: 14726376 Free article. Clinical Trial.

6

BAY 50-4798, a novel, high-affinity receptor-specific recombinant interleukin-2 analog, induces dose-dependent increases in CD25 expression and proliferation among unstimulated, human peripheral blood mononuclear cells in vitro.

Matthews L, Chapman S, Ramchandani MS, Lane HC, Davey RT Jr, Sereti I. Matthews L, et al. Among authors: lane hc. Clin Immunol. 2004 Dec;113(3):248-55. doi: 10.1016/j.clim.2004.07.009. Clin Immunol. 2004. PMID: 15507389

7

Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients.

Keh CE, Shen JM, Hahn B, Hallahan CW, Rehm CA, Thaker V, Wynne SM, Davey RT, Lane HC, Sereti I. Keh CE, et al. Among authors: lane hc. AIDS. 2006 Feb 14;20(3):361-9. doi: 10.1097/01.aids.0000206502.24407.9f. AIDS. 2006. PMID: 16439869

8

CD4+ T cell responses to interleukin-2 administration in HIV-infected patients are directly related to the baseline level of immune activation.

Sereti I, Sklar P, Ramchandani MS, Read SW, Aggarwal V, Imamichi H, Natarajan V, Metcalf JA, Kovacs JA, Tavel J, Davey RT, Dersimonian R, Lane HC. Sereti I, et al. Among authors: lane hc. J Infect Dis. 2007 Sep 1;196(5):677-83. doi: 10.1086/520087. Epub 2007 Jul 16. J Infect Dis. 2007. PMID: 17674308

9

Interferon-alpha produces significant decreases in HIV load.

Tavel JA, Huang CY, Shen J, Metcalf JA, Dewar R, Shah A, Vasudevachari MB, Follmann DA, Herpin B, Davey RT, Polis MA, Kovacs J, Masur H, Lane HC. Tavel JA, et al. Among authors: lane hc. J Interferon Cytokine Res. 2010 Jul;30(7):461-4. doi: 10.1089/jir.2009.0090. J Interferon Cytokine Res. 2010. PMID: 20235638 Free PMC article. Clinical Trial.

10

Elevations in D-dimer and C-reactive protein are associated with the development of osteonecrosis of the hip in HIV-infected adults.

Morse CG, Dodd LE, Nghiem K, Costello R, Csako G, Lane HC, Lozier JN, Kovacs JA. Morse CG, et al. Among authors: lane hc. AIDS. 2013 Feb 20;27(4):591-5. doi: 10.1097/QAD.0b013e32835c206a. AIDS. 2013. PMID: 23169328 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

457 results

Search Page